MIDAMALINE
UNII MK73KA425L

Substance Identification & Data

This profile provides standardized clinical and technical data for Midamaline, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MK73KA425L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 496-38-8 and the RxNorm Concept ID (RxCUI) 2369640. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MK73KA425L

CAS Registry Number

496-38-8

RxNorm Concept ID

2369640

Detailed Substance Profile

Preferred Name

MIDAMALINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H21ClN4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VFSSTMGMWLZGCO-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81411

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

172292

Unique identification number in the NCBI database of chemical substances.

INN ID

548

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1c2c([nH]c1CN(CCN(C)C)c3ccccc3)ccc(c2)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Midamaline. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.